US Stock MarketDetailed Quotes
AUTL Autolus Therapeutics
- 3.270
- +0.175+5.65%
Close Nov 27 16:00 ET
- 3.301
- +0.031+0.94%
Post 19:58 ET
870.22MMarket Cap-2680P/E (TTM)
3.390High3.130Low1.61MVolume3.130Open3.095Pre Close5.29MTurnover1.20%Turnover RatioLossP/E (Static)266.12MShares7.45052wk High1.82P/B439.48MFloat Cap2.69052wk Low--Dividend TTM134.40MShs Float53.240Historical High--Div YieldTTM8.40%Amplitude1.600Historical Low3.284Avg Price1Lot Size
Autolus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 681.04%10.09M | -72.59%1.7M | 0 | -82.86%406K | 0 | 1.29M | 311.02%6.19M | 3.83M |
| Operating revenue | --0 | --0 | 681.04%10.09M | -72.59%1.7M | --0 | -82.86%406K | --0 | --1.29M | 311.02%6.19M | --3.83M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 57.59%67.65M | 31.93%58.52M | 33.20%48.85M | 18.87%177.23M | 256.09%53.27M | -6.40%42.93M | -4.58%44.35M | -12.23%36.67M | 5.08%149.09M | -35.23%14.96M |
| Selling and administrative expenses | 157.56%27.33M | 96.93%21.9M | 95.79%18.18M | 46.54%46.75M | 112.20%15.73M | 28.92%10.61M | 34.50%11.12M | 16.24%9.28M | 0.11%31.9M | -2.36%7.41M |
| -General and administrative expense | 157.56%27.33M | 96.93%21.9M | 95.79%18.18M | 46.54%46.75M | 112.20%15.73M | 28.92%10.61M | 34.50%11.12M | 16.24%9.28M | 0.11%31.9M | -2.36%7.41M |
| Research and development costs | 24.77%40.32M | 10.17%36.61M | 11.99%30.67M | 11.19%130.48M | 397.39%37.54M | -14.12%32.32M | -13.03%33.23M | -19.36%27.39M | 5.88%117.35M | -51.88%7.55M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.83%-166K | --0 |
| Operating profit | -59.10%-67.65M | -31.93%-58.52M | -9.54%-38.76M | -22.84%-175.53M | -378.41%-53.27M | 2.23%-42.52M | 4.58%-44.35M | 15.33%-35.38M | -1.79%-142.89M | 51.79%-11.14M |
| Net non-operating interest income expense | -72.95%-2.37M | 67.97%-518K | -745.51%-12.34M | -338.54%-31.56M | -1,235.20%-27.12M | 18.81%-1.37M | 6.04%-1.62M | 17.20%-1.46M | -753.74%-7.2M | -112.45%-2.03M |
| Non-operating interest income | 128.20%8.32M | 183.75%9.66M | 101.19%6.93M | 690.69%13.51M | 111.08%3.01M | 2,109.70%3.65M | 3,723.60%3.4M | 12,207.14%3.45M | 551.91%1.71M | 857.05%1.43M |
| Non-operating interest expense | 113.12%10.69M | 102.67%10.17M | 292.84%19.27M | 406.09%45.07M | 771.51%30.13M | 171.03%5.01M | 177.35%5.02M | 174.02%4.91M | 705.88%8.91M | 212.85%3.46M |
| Other net income (expense) | -509.04%-12.05M | 76.91%812K | 46.25%-1.61M | -186.15%-1.31M | -44.33%3.19M | 47.09%-1.98M | 134.49%459K | -447.21%-2.99M | 285.51%1.52M | 6,474.44%5.74M |
| Gain on sale of security | -585.75%-11.88M | ---- | ---- | ---- | ---- | ---1.73M | ---- | ---- | ---- | ---- |
| Special income (charges) | 41.62%-223K | -1,700.00%-414K | --0 | -710.29%-4.17M | --0 | ---382K | ---23K | ---3.77M | 23.82%-515K | -12,775.00%-515K |
| -Less:Impairment of capital assets | --0 | --414K | ---- | --382K | --0 | --382K | --0 | ---- | --0 | --0 |
| -Gain on sale of property,plant,equipment | ---223K | --0 | --0 | -636.12%-3.79M | --0 | --0 | ---23K | ---3.77M | 23.82%-515K | -12,775.00%-515K |
| Other non- operating income (expenses) | -60.29%54K | 154.36%1.23M | -305.24%-1.61M | 40.38%2.86M | -55.98%2.75M | 103.64%136K | 136.21%482K | -9.07%782K | 1,505.52%2.04M | 7,369.77%6.25M |
| Income before tax | -78.92%-82.07M | -27.92%-58.22M | -32.32%-52.7M | -40.27%-208.4M | -939.10%-77.2M | 6.23%-45.87M | 8.12%-45.51M | 6.70%-39.83M | -4.60%-148.57M | 69.23%-7.43M |
| Income tax | 204.76%22K | 27.50%51K | 42.86%-8K | -106.99%-19K | -100.12%-24K | 99.66%-21K | 100.54%40K | 99.75%-14K | 368.97%272K | 11.40%19.52M |
| Net income | -79.05%-82.09M | -27.92%-58.27M | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.21%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M |
| Net income continuous Operations | -79.05%-82.09M | -27.92%-58.27M | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.21%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -79.05%-82.09M | -27.92%-58.27M | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.21%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -79.05%-82.09M | -27.92%-58.27M | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.21%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M |
| Basic earnings per share | -19.23%-0.31 | 15.38%-0.22 | -4.35%-0.24 | 23.57%-1.2 | -95.65%-0.45 | 44.68%-0.26 | 43.48%-0.26 | 43.90%-0.23 | 20.30%-1.57 | 54.90%-0.23 |
| Diluted earnings per share | -19.23%-0.31 | 15.38%-0.22 | -4.35%-0.24 | 23.57%-1.2 | -95.65%-0.45 | 44.68%-0.26 | 43.48%-0.26 | 43.90%-0.23 | 20.30%-1.57 | 54.90%-0.23 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data